Target 2035 – Webinar Series

HOW will we achieve Target 2035 goals – new technology and approaches

Moderator: Matthew Hall (National Center for Advancing Translational Sciences, NIH)
Accelerating Chemistry
5 min Matthew Hall (National Center for Advancing Translational Sciences, NIH) Welcome and introduction
15 min Angela Koehler (MIT) Expanding the repertoire of druggable targets
15 min Jacob Bush (GSK) Reactive fragment platforms for the identification of chemical tools
15 min Damian Young (Baylor College of Medicine) Systematic chemical diversity to enable probe and drug development
10 min Discussion and audience Q&A
Accelerating Chemical Biology
15 min Alison Axtman (SGC- University of North Carolina at Chapel Hill) Design of the first selective chemical probe for the pleiotropic kinase CK2
15 min John Meier (National Cancer Institute, NIH) Chemoproteomic platforms to validate
and discover probe targets
15 min Michelle Arkin (University of California San Francisco) Chemical biology of protein-protein interactions
15 min Discussion and audience Q&A